{
    "code": "52028005",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52028005",
    "time": "2022-09-23 04:15:50",
    "許可證字號": "衛部藥輸字第028005號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/01\/15",
    "發證日期": "110\/01\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202800509",
    "中文品名": "愛乳適膜衣錠75毫克",
    "英文品名": "Ibrance Film-coated Tablets 75 mg",
    "適應症": "(1) 對於荷爾蒙受體為陽性、第二型人類表皮生長因子接受體(HER2)呈陰性之局部晚期或轉移性乳癌之婦女或男性， IBRANCE 可與芳香環轉化酶抑制劑(aromatase inhibitor)合併使用。\r\n(2) 對於荷爾蒙受體為陽性、第二型人類表皮生長因子接受體(HER2)呈陰性之局部晚期或轉移性乳癌之病人，IBRANCE可合併fulvestrant用於先前曾接受過內分泌治療者。\r\n說明：停經前\/停經前後(pre\/perimenopause)婦女，接受內分泌治療應合併黃體生成素-釋放激素(luteinizing hormone-releasing hormone；LHRH)致效劑。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠PVC\/OPA\/Al\/PVC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新劑型",
    "監視期限": "",
    "主成分略述": "palbociclib",
    "限制項目": "02輸　入 1L監視中新藥",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0247000  PFIZER MANUFACTURING DEUTSCHLAND GMBH",
            "製造廠廠址": "BETRIEBSSTATTE FREIBURG, MOOSWALDALLEE 1, 79090 FREIBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓、3樓、1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013006000",
            "成分名稱": "palbociclib",
            "含量描述": "",
            "含量": "75.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "1. IBRANCE Tablet LLD SPC 20210716-1-111-04-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028005&Seq=002&Type=9"
        },
        {
            "title": "Ibrance 75mg Foil-110-03-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028005&Seq=002&Type=8"
        },
        {
            "title": "Ibrance 75mg CTN-110-03-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028005&Seq=001&Type=8"
        }
    ]
}